A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human Volunteers

Background. A key missing element in the development of a successful human immunodeficiency virus (HIV) vaccine is an immunogen that can generate broadly cross-neutralizing antibodies against primary isolates of the virus. Methods. This phase 1 clinical trial employed a DNA prime and subunit envelop...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Spearman, Paul, Lally, Michelle A., Elizaga, Marnie, Montefiori, David, Tomaras, Georgia D., McElrath, M. Juliana, Hural, John, De Rosa, Stephen C., Sato, Alicia, Huang, Yunda, Frey, Sharon E., Sato, Paul, Donnelly, John, Barnett, Susan, Corey, Lawrence J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2011
Aiheet:
Major Articles and Brief Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068023/
https://ncbi.nlm.nih.gov/pubmed/21451004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiq175
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia